Kiora Pharmaceuticals (KPRX) Live Share Price, Invest From India

Kiora Pharmaceuticals Stock Performance

as on October 31, 2026 at 2:15 pm IST

Day's Low
Day's High
$1.55
Day's Price Range
$1.76
$1.56
0.64%
Downside
12.82%
Upside
52 Week's Low
52 Week's High
$1.73
52-Week Price Range
$2.91
$1.56
-10.90%
Downside
86.54%
Upside

Kiora Pharmaceuticals share price movements today

Previous Close: $1.76
Open: $1.76
Volume: 341.6K
Market Cap: $10.4M
Day's Low - High: $1.55 - $1.76
52 Week Low - High: $1.73 - $2.91

Kiora Pharmaceuticals Historical Returns

1 Month Return: -31.25 %
3 Month Return: -31.12 %
1 Year Return: -30.98 %
3 Year Return: -67.41 %
5 Year Return: 0 %

Kiora Pharmaceuticals Stock Fundamentals & Key Indicators

Check Kiora Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$10.4M

EPS (TTM)

-2.5038

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.94

Industry PE ratio

-2.98

PEG Ratio

-0.04

EBITDA

-12.2M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-63.39%

Kiora Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kiora Pharmaceuticals with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Kiora Pharmaceuticals	Buy	$10.4M	NA	-0.94	0.00%	0.00%
Moderna	Neutral	$85.5B	-35.47%	-26.84	-12.57%	0.00%
Vertex Pharmaceuticals	StrongBuy	$134.2B	192.00%	30.58	86.04%	0.00%
Regeneron	Buy	$83.7B	27.94%	19.42	84.86%	0.45%

Stock Returns calculator for Kiora Pharmaceuticals Stock including INR - Dollar returns

The Kiora Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Kiora Pharmaceuticals investment value today

Current value as on today

₹65,437

Returns

-₹34,563

(-34.56%)

Returns from Kiora Pharmaceuticals Stock

-₹38,824 (-38.82%)

Dollar Impact

₹4,260 (+4.26%)

Analyst Recommendation on Kiora Pharmaceuticals Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Kiora Pharmaceuticals. Average target price of $12

Kiora Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on Kiora Pharmaceuticals.

What analysts predicted

87%UPSIDE

Target Price

$12

Current Price

$1.56

Analyzed by

8 Analysts

Target

$12.00

Kiora Pharmaceuticals target price $12, a slight upside of 87% compared to current price of $1.56. According to 8 analysts rating.

Indian Investors' Interest in Kiora Pharmaceuticals Stock

Search interest for Kiora Pharmaceuticals Stock has increased by 136% in the last 30 days, reflecting an upward trend in search activity.

Time period: October 2, 2026 to November 1, 2026

Change:136% versus previous 30 day period

Kiora Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	16	-	-	-	-	-	-	-	-	-
Gross Profit	16	-	-	-	-	-	-	-	0	-
Operating Income	13	-2	-3	-2	-2	-2	0	-7	-2	-2
EBITDA	13	-2	-2	-2	-2	-2	-2	-5	-2	-2
Interest Expense	-	-	-	0	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	13	-2	-3	-2	-2	-2	0	-7	-2	-2
Income Tax Expense	-	-	-	2	0	0	0	0	-	-
Net Income	13	-2	-3	-4	-2	-2	0	-6	-2	-2
Net Profit Margin	100.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Kiora Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	0	1	2	0	-	-	-	16	-
Gross Profit	-9	-6	2	-3	-	-	-	16	0
Operating Income	-14	-10	-7	-6	-14	-12	-12	4	-9
EBITDA	-14	-10	-6	-7	-13	-13	-12	5	-12
Interest Expense	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0
Income Before Tax	-14	-10	-7	-6	-13	-13	-12	5	-12
Income Tax Expense	-1	0	0	0	0	0	0	2	-1
Net Income	-13	-10	-7	-6	-13	-13	-12	3	-10
Net Profit Margin	-2434.94%	-387.48%	99.82%	-27038.66%	0.00%	0.00%	0.00%	100.00%	0.00%

Kiora Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	13	-2	-3	-4	-2	-2	0	-6	-2	-2
Operating Cash Flow	13	-3	0	-2	-2	-3	-1	-2	-3	-1
Investing Cash Flow	-	-21	-1	0	2	0	5	5	5	-6
Financing Cash Flow	15	0	-	-	-	0	-	0	0	4
Change in Cash	28	-24	0	-1	0	-2	4	3	2	-3

Kiora Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-13	-10	-7	-6	-13	-13	-12	3	-10
Operating Cash Flow	-6	-10	-8	-7	-10	-10	-9	8	-9
Investing Cash Flow	0	0	-	0	0	0	-	-22	14
Financing Cash Flow	10	11	3	4	17	8	5	15	0
Change in Cash	4	0	-4	-2	6	-1	-3	1	4

Global Institutional Holdings in Kiora Pharmaceuticals

Check out the Institutions with significant holdings in Kiora Pharmaceuticals.

Funds	Holdings
Joseph Edelman	9.91%
Fidelity Concord Street Trust	0.56%
Vanguard	0.50%
VANGUARD INDEX FUNDS	0.45%
DFA	0.11%

See all

Insights on Kiora Pharmaceuticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 720.2% return, outperforming this stock by 744.0%
NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 193.3% return, outperforming this stock by 260.2%
NEGATIVE IMPACT
Price Dip
In the last 7 days, KPRX stock has moved down by -23.1%

About Kiora Pharmaceuticals

Kiora Pharmaceuticals, Inc., a specialty pharmaceutical firm operating at the clinical stage, is dedicated to the creation and commercialization of treatments for various ophthalmic conditions across the United States. Its flagship therapeutic candidate, KIO-301, is a groundbreaking small molecule undergoing Phase 1 clinical trials. This innovative "photoswitch" aims to revitalize vision in individuals suffering from both inherited and age-related forms of retinal degeneration. The company's pipeline also includes KIO-101, an eye drop currently in Phase 2 trials for addressing the ocular manifestations of rheumatoid arthritis, as well as non-infectious posterior uveitis. Furthermore, Kiora is advancing KIO-201, another eye drop, which is in Phase 3 clinical trials, designed to facilitate corneal wound healing following PRK surgery. Established in 1998, the company adopted its current name in November 2021, having previously operated as Eyegate Pharmaceuticals, Inc. Kiora Pharmaceuticals maintains its corporate headquarters in Salt Lake City, Utah.

Organisation	Kiora Pharmaceuticals
Headquarters	332 Encinitas Boulevard, Encinitas, CA, 92024, US
Industry	Biotechnology
CEO	Brian Strem

Key Management of Kiora Pharmaceuticals

Name	Title
Ms. Melissa Tosca CPA	Chief Financial Officer
Dr. Stefan Sperl Ph.D.	Executive Vice President of CMC & Operations
Mr. Keith J. Lane M.B.A.	Executive VP and Head of Clinical Development & Regulatory Affairs
Dr. Brian M. Strem Ph.D.	President, CEO & Director

FAQs

What is Kiora Pharmaceuticals share price today?

Kiora Pharmaceuticals share price today is $1.56 as on October 31, 2026 at 8:45 am IST at the close of the market. Kiora Pharmaceuticals share today touched a day high of $1.76 and a low of $1.55.

What is the 52 week high and 52 week low for Kiora Pharmaceuticals share?

Kiora Pharmaceuticals share touched a 52 week high of $2.91 on April 8, 2026 and a 52 week low of $1.73 on October 29, 2026. Kiora Pharmaceuticals stock price today i.e. October 31, 2026 at 8:45 am IST is closed at $1.56,which is 46.39% down from its 52 week high and -9.83% up from its 52 week low.

What is Kiora Pharmaceuticals's market capitalisation today?

Kiora Pharmaceuticals market capitalisation is $0.00T as on October 31, 2026 at 8:45 am IST.

How to invest in Kiora Pharmaceuticals Stock (KPRX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Kiora Pharmaceuticals on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Kiora Pharmaceuticals Stock (KPRX) from India?

Indian investors can start investing in Kiora Pharmaceuticals (KPRX) shares with as little as ₹94.94999694824219 or $1 (as of November 1, 2026 at 5:38 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.50 in Kiora Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on November 1, 2026 at 5:38 am IST). Based on Kiora Pharmaceuticals share’s latest price of $1.56 as on October 31, 2026 at 8:45 am IST, you will get 6.4103 shares of Kiora Pharmaceuticals. Learn more about fractional shares .